What is startup experience?

Startup experience means you’ve operated in a setting where the goal is to create a repeatable business from uncertainty—usually with limited time, money, and people. It’s less about your job title (“founder,” “CTO,” “PM”) and more about proof you can ship, learn, and adapt when the plan is wrong.

For medtech founders, startup experience has a specific flavor: you’re not only building a product—you’re navigating regulatory (FDA), clinical evidence (IRB, studies), reimbursement (CPT/coverage), and hospital procurement (value analysis committees, contracting). A brilliant prototype is not “startup experience” unless it’s connected to a path to adoption and payment.

Startup experience vs. “working at a startup”

Many people assume startup experience equals “I worked at a startup.” That can help, but it’s not the definition. Startup experience is about having done the work that reduces risk and moves a venture from idea to something customers buy and use.

Here’s a practical way to think about it:

• Employment context: You were on a small team with high ambiguity.
• Behavioral evidence: You repeatedly made decisions with incomplete data, ran experiments, and changed course.
• Outcome evidence: You can point to measurable progress (users, pilots, LOIs, regulatory milestones, revenue, retention, manufacturing readiness).

In medtech, “outcome evidence” often looks like: a defined FDA pathway (510(k), De Novo, or PMA), a credible clinical evaluation plan, a reimbursement strategy, and a procurement-ready value story.

What counts as startup experience in medtech (the proof points)

Investors, advisors, and early hires look for signals that you can de-risk the business. In medtech, the strongest signals usually fall into five buckets.

1) Customer discovery with the economic buyer (not just users)

Talking to clinicians is necessary but not sufficient. Startup experience includes interviewing the people who control adoption:

• Department leadership (service line owners)
• Hospital procurement / supply chain
• Value Analysis Committee (VAC) stakeholders
• Revenue cycle / coding team (for reimbursement implications)

Evidence: documented interviews, a clear problem statement, and a defined buyer/user/payer map. (Buyer = who signs; user = who uses; payer = who reimburses.)

2) Regulatory strategy that matches the product and claims

In medtech, startup experience often means you can translate a clinical idea into a regulatory plan. That includes:

• Choosing a likely FDA pathway: 510(k) (substantial equivalence), De Novo (novel moderate-risk), or PMA (high-risk, most evidence-heavy).
• Defining intended use, indications for use, and claims that are realistic for early evidence.
• Understanding what verification/validation and clinical evidence might be needed (details vary by device and risk).

Evidence: a one-page regulatory memo, a draft claims matrix, and a risk-based development plan. You don’t need to be a regulatory expert, but you need to show you can manage the process and avoid “science project” drift.

3) Clinical validation planning (IRB, endpoints, workflow)

Clinical work is where many STEM founders already have strengths, but startup experience is about connecting clinical validation to adoption. That means:

• Picking endpoints that matter to decision-makers (clinical outcomes, time saved, complications reduced, throughput, readmissions—depending on context).
• Designing a study that fits real workflow and can actually recruit.
• Knowing when IRB approval is required and planning timelines and responsibilities.

Evidence: a draft protocol outline, inclusion/exclusion logic, and a plan for data capture that doesn’t collapse under clinical reality.

4) Reimbursement and pricing logic (CPT, coverage, payment)

Reimbursement is not a “later” problem in many medtech categories. Startup experience includes understanding whether you’re:

• Using existing CPT codes vs. needing a new code (timelines vary).
• Relying on facility payment (hospital) vs. professional payment (physician).
• Creating economic value that can be expressed in a simple ROI story for the hospital.

Evidence: a basic reimbursement landscape summary, a draft pricing hypothesis, and a value proposition tied to a measurable economic lever (e.g., reduced OR time, fewer complications, fewer repeat visits). Specific amounts vary; the key is having a defensible logic chain.

5) Go-to-market execution inside hospital constraints

Startups win by moving from “interest” to “commitment.” In hospitals, that means navigating pilots, contracting, and stakeholder alignment. Startup experience includes:

• Running a pilot with clear success criteria and a champion.
• Understanding procurement steps (vendor onboarding, security review for digital health, VAC review for devices).
• Creating sales assets that match the buyer: clinical evidence summary, workflow impact, and economic case.

Evidence: a pilot plan, a letter of intent (LOI) or evaluation agreement, or documented progress through procurement gates.

A simple framework: “De-risking milestones” instead of resumes

If you’re trying to explain your startup experience (to cofounders, investors, accelerators, or even yourself), use a milestone-based narrative. A useful structure is:

1. Risk: What could kill the company? (clinical, regulatory, reimbursement, adoption, technical feasibility)
2. Assumption: What did you believe that needed proof?
3. Test: What experiment or artifact reduced that risk?
4. Result: What changed because of the test?
5. Next bet: What’s the next highest-risk assumption?

This is startup experience: a repeated loop of identifying the biggest risk and reducing it with the smallest credible step.

How to get startup experience fast (without quitting medicine or research)

You can build real startup experience part-time if you focus on high-leverage actions. In medtech, the fastest credibility comes from customer discovery plus a clear regulatory/reimbursement direction.

• Do 20–30 structured interviews across user, buyer, and payer-adjacent roles. Summarize patterns, not anecdotes.
• Write a one-page “path to market”: intended use, likely FDA pathway (510(k)/De Novo/PMA), evidence plan, and who pays.
• Run a workflow prototype test: not a perfect product—something that proves integration points and adoption barriers.
• Secure a clinical champion and define a pilot success metric (time saved, error reduction, adherence, etc.).

If you can show you’ve done these steps, you have startup experience—even if you’ve never had “startup” in your job title.

Common misconceptions (especially among STEM/clinical founders)

• “I built a prototype, so I have startup experience.” Not unless it’s tied to a buyer, a workflow, and a path through regulatory/reimbursement.
• “Publishing a paper equals validation.” Publications help credibility, but adoption requires operational proof: procurement, integration, training, and economics.
• “Regulatory is a checkbox at the end.” In medtech, regulatory strategy shapes product design, claims, evidence, timelines, and cost from day one.
• “Hospitals buy like consumers.” They don’t. Multiple stakeholders, committees, and contracting steps can dominate timelines.

What to do next

1. Write your “startup experience” as 5 de-risking milestones (risk → test → result), not as a resume paragraph.
2. Map your buyer/user/payer for your medtech idea and schedule 10 interviews in the next 14 days.
3. Draft a one-page regulatory + evidence plan that names a likely FDA pathway (510(k), De Novo, or PMA) and what proof you’ll need (varies by device).
4. Build a procurement-ready value story: one clinical benefit + one economic lever + how you’ll measure it in a pilot.

Want feedback on whether your current work “counts” as startup experience in medtech? Use the tools below to pressure-test your plan.